Capretz & Associates is investigating claims of potential defects in the Sorin Mitroflow aortic prosthesis heart valve. The bioprosthetic (tissue) valve has been linked to early structural valve deterioration (SVD). Cusp tears and thickening, calcification, pannus formation, and thrombus can lead to the early deterioration of the valve, which may require a reoperation to replace the failed valve. In some cases, the Mitroflow valve had to be replaced in less than five (5) years.
If you or someone you know had a Sorin Mitroflow tissue valve implanted and had to have it replaced within five (5) years, contact us for a free legal consultation. Call us toll-free at: (800) 351-8588.